Sort   by:  
 Page size 
UnknownGenetic Variants of Homocysteine Metabolism, Homocysteine, and Frailty - Rugao Longevity and Ageing Study.
Not available
S-EPMC12879093 | biostudies-literature
UnknownSupportive care needs of patients who had a stroke: a scoping review protocol.
Not available
S-EPMC10450070 | biostudies-literature
UnknownThe gut microbiome and metabolites are altered and interrelated in patients with functional constipation.
Not available
S-EPMC10731029 | biostudies-literature
UnknownMORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer.
Not available
S-EPMC11715975 | biostudies-literature
UnknownImpact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis.
Not available
S-EPMC7559685 | biostudies-literature
ProteomicsProteomic Characterization of Epithelial Ovarian Cancer Delineates Molecular Signatures and Therapeutic Targets in Distinct Histological Subtypes
Clear cell carcinoma (CCC), endometrioid carcinoma (EC), and serous carcinoma (SC) are the major histological subtypes of epithelial ovarian cancer (EOC), whose differences in carcinogenesis are still unclear. Here, we undertake comprehensive proteomic profiling of 80 CCC, 79 EC, 80 SC, and 30 contr...
ORGANISM(S): Homo sapiens (Human) 
2023-10-30 | PXD033741 | Pride
Epithelial ovarian cancer proteomics histological subtype tumor biomarkers drug target 
UnknownSingle-plane versus real-time biplane approaches for ultrasound-guided central venous catheterization in critical care patients: a randomized controlled trial.
Not available
S-EPMC10517529 | biostudies-literature
UnknownProteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes.
Not available
S-EPMC10684593 | biostudies-literature
ProteomicsUrinary proteomics analysis of active vitiligo patients
Vitiligo is a common acquired skin disorder caused by immune-mediated destruction of epidermal melanocytes. Systemic glucocorticoids (GCs) have been used to prevent the progression of active vitiligo, with 8.2%–56.2% of patients insensitive to this therapy. Currently, there is a lack of biomarkers t...
ORGANISM(S): Homo Sapiens 
2022-02-11 | PXD031595 |
UnknownConvergent genomic signatures of high-altitude adaptation among domestic mammals.
Not available
S-EPMC8288980 | biostudies-literature
Sort   by:  
 Page size